Provider‐ and patient‐level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinoma

Provider‐ and patient‐level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinoma

Abstract Background Improving oral anticancer agent (OAA) initiation and adherence is the important quality‐of‐care issues, particularly since one fourth of anticancer agents being developed will be administered orally. Our objective was to identify provider‐ and patient‐level characteristics associ...

Full description

Bibliographic Details
Main Authors: Lisa P. Spees, Stephanie B. Wheeler, Bradford E. Jackson, Christopher D. Baggett, Lauren E. Wilson, Melissa A. Greiner, Deborah R. Kaye, Tian Zhang, Daniel George, Charles D. Scales Jr, Jessica E. Pritchard, Michael Leapman, Cary P. Gross, Michaela A. Dinan
Format: Article
Language:English
Published: Wiley 2021-10-01
Series:Cancer Medicine
Subjects:
adherence
initiation
metastatic
oral anticancer agents
renal cell carcinoma
Online Access:https://doi.org/10.1002/cam4.4201

Internet

https://doi.org/10.1002/cam4.4201

Similar Items